Dysmyelination by Oligodendrocyte‐Specific Ablation of Ninj2 Contributes to Depressive‐Like Behaviors
Source abstract
Abstract
Abstract Depression is a mental disorder affecting more than 300 million people in the world. Abnormalities in white matter are associated with the development of depression. Here, the authors show that mice with oligodendrocyte‐specific deletion of Nerve injury‐induced protein 2 (Ninj2) exhibit depressive‐like behaviors. Loss of Ninj2 in oligodendrocytes inhibits oligodendrocyte development and myelination, and impairs neuronal structure and activities. Ninj2 competitively inhibits TNFα/TNFR1 signaling pathway by directly binding to TNFR1 in oligodendrocytes. Loss of Ninj2 activates TNFα‐induced necroptosis, and increases C‐C Motif Chemokine Ligand 2 (Ccl2) production, which might mediate the signal transduction from oligodendrocyte to neurons. Inhibition of necroptosis by Nec‐1s administration synchronously restores oligodendrocyte development, improves neuronal excitability, and alleviates depressive‐like behaviors. This study thus illustrates the role of Ninj2 in the development of depression and myelination, reveals the relationship between oligodendrocytes and neurons, and provides a potential therapeutic target for depression.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neurogenesis and neuroplasticity mechanisms · RNA Research and Splicing · Neuroscience and Neuropharmacology Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Cellular Stress Biology School of Life Sciences Xiamen University Xiamen Fujian 361005 China
Shanghai Key Laboratory of Metabolic Remodeling and Health Institute of Metabolism and Integrative Biology Zhongshan Hospital Fudan University Shanghai 200438 China
Department of Endocrinology and Diabetes The First Affiliated Hospital of Xiamen University Fujian Province Key Laboratory of Diabetes Translational Medicine Xiamen Fujian 361101 China
Funding
National Natural Science Foundation of China
References (68)
Show source-provided references
1. 10.1038/s41380-020-00930-010.1038/s41380-020-00930-0 ↗
2. 10.1016/S0140-6736(18)31948-210.1016/S0140-6736(18)31948-2 ↗
3. 10.1016/j.nicl.2016.08.01610.1016/j.nicl.2016.08.016 ↗
4. 10.1155/2012/87438710.1155/2012/874387 ↗
5. 10.1007/s11682-016-9645-z10.1007/s11682-016-9645-z ↗
6. 10.1152/physrev.2001.81.2.87110.1152/physrev.2001.81.2.871 ↗
7. Nave K. A. · J. Neuroimmunol. · 2006 · 178 · 36
8. 10.1038/nn.425810.1038/nn.4258 ↗
9. 10.1038/nm.448310.1038/nm.4483 ↗
10. 10.1073/pnas.180262011510.1073/pnas.1802620115 ↗
11. 10.1016/j.devcel.2017.03.00110.1016/j.devcel.2017.03.001 ↗
12. 10.1016/j.devcel.2018.05.02210.1016/j.devcel.2018.05.022 ↗
13. 10.1007/978-981-32-9636-7_210.1007/978-981-32-9636-7_2 ↗
14. 10.1111/jnc.1298810.1111/jnc.12988 ↗
15. 10.1038/ncomms951810.1038/ncomms9518 ↗
16. 10.3389/fncel.2018.0048210.3389/fncel.2018.00482 ↗
17. 10.1192/bjp.bp.111.10059410.1192/bjp.bp.111.100594 ↗
18. 10.1016/j.biopsych.2010.07.02810.1016/j.biopsych.2010.07.028 ↗
19. 10.1016/j.biopsych.2006.03.05210.1016/j.biopsych.2006.03.052 ↗
20. 10.1016/j.jpsychires.2015.04.01010.1016/j.jpsychires.2015.04.010 ↗
21. 10.1176/appi.ajp.161.7.129310.1176/appi.ajp.161.7.1293 ↗
22. 10.1523/JNEUROSCI.20-01-00187.200010.1523/JNEUROSCI.20-01-00187.2000 ↗
23. 10.1523/JNEUROSCI.1860-14.201410.1523/JNEUROSCI.1860-14.2014 ↗
24. Li B. H. · J. Neurosci. · 2012 · 316 · 116
25. 10.1007/s11011-019-00460-x10.1007/s11011-019-00460-x ↗
26. Zhang Z. · J. Neurosci. · 2015 · 357 · 58
27. 10.1007/s12031-020-01584-x10.1007/s12031-020-01584-x ↗
28. 10.1038/nm.438610.1038/nm.4386 ↗
29. 10.1016/j.biopsych.2018.11.02510.1016/j.biopsych.2018.11.025 ↗
30. 10.1016/j.psychres.2006.12.01910.1016/j.psychres.2006.12.019 ↗
31. 10.1038/srep4654810.1038/srep46548 ↗
32. 10.1038/s41593-020-0621-y10.1038/s41593-020-0621-y ↗
33. 10.1515/RNS.2011.04410.1515/RNS.2011.044 ↗
34. 10.1001/jamapsychiatry.2013.110.1001/jamapsychiatry.2013.1 ↗
35. 10.1038/s41586-020-03047-010.1038/s41586-020-03047-0 ↗
36. 10.1371/journal.pbio.100199310.1371/journal.pbio.1001993 ↗
37. 10.1016/j.neuron.2015.10.04610.1016/j.neuron.2015.10.046 ↗
38. 10.1016/S0140-6736(03)14289-410.1016/S0140-6736(03)14289-4 ↗
39. 10.1016/j.jad.2010.03.02710.1016/j.jad.2010.03.027 ↗
40. 10.1001/archpsyc.64.2.20910.1001/archpsyc.64.2.209 ↗
41. 10.1017/S146114570700763810.1017/S1461145707007638 ↗
42. 10.1016/j.schres.2014.03.03510.1016/j.schres.2014.03.035 ↗
43. 10.1016/j.celrep.2015.02.05110.1016/j.celrep.2015.02.051 ↗
44. 10.1016/j.bbrc.2016.09.04210.1016/j.bbrc.2016.09.042 ↗
45. 10.1038/nchembio71110.1038/nchembio711 ↗
46. 10.1016/j.molcel.2019.05.02210.1016/j.molcel.2019.05.022 ↗
47. 10.1038/s41380-019-0474-510.1038/s41380-019-0474-5 ↗
48. 10.1093/neuonc/noz21410.1093/neuonc/noz214 ↗
49. 10.1002/jnr.2061210.1002/jnr.20612 ↗
50. 10.1016/j.neuroscience.2009.05.04810.1016/j.neuroscience.2009.05.048 ↗
51. 10.1038/s41386-018-0115-810.1038/s41386-018-0115-8 ↗
52. 10.1126/science.aaf680310.1126/science.aaf6803 ↗
53. 10.3389/fncel.2016.0002710.3389/fncel.2016.00027 ↗
54. 10.1038/mp.2012.8410.1038/mp.2012.84 ↗
55. 10.1016/j.pnpbp.2017.08.00910.1016/j.pnpbp.2017.08.009 ↗
56. 10.1073/pnas.070215710410.1073/pnas.0702157104 ↗
57. 10.1007/s00415-005-0963-010.1007/s00415-005-0963-0 ↗
58. 10.1007/s00415-007-2017-210.1007/s00415-007-2017-2 ↗
59. 10.1016/j.celrep.2019.02.06010.1016/j.celrep.2019.02.060 ↗
60. 10.1038/jcbfm.2009.24010.1038/jcbfm.2009.240 ↗
61. 10.1007/s43440-021-00280-w10.1007/s43440-021-00280-w ↗
62. 10.1038/nn.406610.1038/nn.4066 ↗
63. 10.1126/science.125230410.1126/science.1252304 ↗
64. 10.1038/nprot.2007.14910.1038/nprot.2007.149 ↗
65. 10.1016/j.neuron.2018.08.03110.1016/j.neuron.2018.08.031 ↗
66. 10.1016/j.cell.2018.05.00210.1016/j.cell.2018.05.002 ↗
67. 10.1016/j.celrep.2016.10.04710.1016/j.celrep.2016.10.047 ↗
68. 10.1016/j.neuron.2019.09.04210.1016/j.neuron.2019.09.042 ↗